tiprankstipranks
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market

Rhythm Pharmaceuticals (RYTM) Income Statement

Compare
483 Followers

Rhythm Pharmaceuticals Income Statement

Last quarter (Q4 2024), Rhythm Pharmaceuticals's total revenue was $41.83M, an increase of 72.61% from the same quarter last year. In Q4, Rhythm Pharmaceuticals's net income was $-43.29M. See Rhythm Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 130.13M$ 77.43M$ 23.64M$ 3.15M$ 0.00
Gross Profit
$ 116.76M$ 68.13M$ 21.50M$ 2.56M$ -690.00K
Operating Expenses
$ 382.26M$ 252.48M$ 200.66M$ 172.61M$ 136.57M
Depreciation and Amortization
$ 1.56M$ 1.76M$ 1.40M$ 1.16M$ 690.00K
EBITDA
$ -238.09M$ -168.46M$ -174.51M$ -68.45M$ -135.88M
Operating Income
$ -265.50M$ -184.36M$ -179.16M$ -170.06M$ -136.57M
Other Income/Expenses
$ 5.25M$ 243.00K$ -1.96M$ 100.45M$ 2.58M
Pretax Income
$ -260.26M$ -184.11M$ -181.12M$ -69.61M$ -134.00M
Net Income
$ -260.60M$ -184.68M$ -183.08M$ -68.01M$ -130.73M
Per Share Metrics
Basic EPS
$ -4.27$ -3.20$ -3.51$ -1.37$ -2.96
Diluted EPS
$ -4.27$ -3.20$ -3.51$ -1.37$ -2.96
Weighted Average Shares Outstanding
61.00M 57.67M 52.12M 49.60M 44.13M
Weighted Average Shares Outstanding (Diluted)
61.00M 57.67M 52.12M 49.60M 44.13M
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis